Ireland
--:--IST
Latest
Clinical Trials in Turkey / NCT07595406
Starting soon Not applicable

Cervical Medial Branch Block Versus Ipsilateral Cervical Erector Spinae Plane Block

NCT07595406 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2026-05-31
Last updated
2026-05-19

Condition(s) studied

Cervical Facetogenic PainChronic Neck PainCervical Facet Joint Syndrome

Investigational drug(s) / intervention(s)

Ultrasound-guided cervical medial branch blockUltrasound-guided cervical erector spinae plane block

Ultrasound-guided cervical medial branch block: Ultrasound-guided cervical medial branch block performed at clinically suspected symptomatic cervical facet levels using local anesthetic for diagnostic and analgesic purposes.

Ultrasound-guided cervical erector spinae plane block: Ultrasound-guided ipsilateral cervical erector spinae plane block performed at the symptomatic cervical level using local anesthetic for analgesic purposes.

Study summary

This prospective randomized controlled study aims to compare the analgesic effectiveness of ultrasound-guided cervical medial branch block and ipsilateral cervical erector spinae plane block in patients with cervical facetogenic pain.

Patients with chronic cervical facet-mediated pain will be randomized into two intervention groups. Pain intensity, functional status, meaningful pain response rates, analgesic consumption, and patient satisfaction will be evaluated during follow-up.

The primary objective is to determine whether cervical erector spinae plane block provides comparable short-term pain relief to cervical medial branch block.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Age between 18 and 80 years * Chronic neck pain lasting at least 3 months * Clinical findings suggestive of cervical facetogenic pain * Numeric Rating Scale pain score ≥4 * Ability to provide informed consent Exclusion Criteria: * Cervical radiculopathy or myelopathy * Major neurological deficit * Infection at the injection site * Coagulopathy or anticoagulant therapy contraindicating intervention * Allergy to local anesthetics * Pregnancy * Previous cervical interventional pain procedure within the last 3 months * Severe psychiatric disease

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Ankara Bilkent City Hospital Ankara Ankara

More Ankara City Hospital Bilkent trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07595406 on ClinicalTrials.gov ↗ ← All trials in Turkey